Amsterdam UMC - Amsterdam Neuroscience
Micha Wilhelmus is an accomplished academic and researcher with extensive experience in the field of neurodegeneration and pharmacology. Currently serving as an Associate Professor at Amsterdam UMC since 2007, Micha has focused on the therapeutic potential of transglutaminases to address neurodegenerative diseases. In parallel, Micha holds various leadership roles at VU Amsterdam, including Program Director of the Bachelor's degree in Biomedical Sciences and multiple chair positions on different education boards. Micha has also contributed to the Dutch Pharmacological Society and served as a Clinical Scientist at the Centre for Human Drug Research. With a solid educational background culminating in a PhD from Radboud University, Micha has established a significant presence in both education and research related to neuroscience and pharmacology.
This person is not in any teams
Amsterdam UMC - Amsterdam Neuroscience
Amsterdam Neuroscience is the research institute for neuroscience of Amsterdam UMC and the science faculties of Vrije Universiteit Amsterdam and the University of Amsterdam. Researchers and clinicians from these three institutions join forces in the field of fundamental, translational and clinical brain research. This collaboration strengthens the scientific excellence in this area, making Amsterdam Neuroscience one of the largest neuroscience communities in Europe. To enable translational neuroscience research, we develop and translate neuroscience knowledge into applications for patients. Amsterdam Neuroscience focuses on scientific excellence, young talent and innovation in four cross-disciplinary research programs. In addition, there are five clinical research programs that focus on both existing and new treatments for a number of brain and nervous system diseases, including neurological, neurovascular and psychiatric disorders. Amsterdam Neuroscience’s overall mission is to broaden the fundamental knowledge of the human brain and nervous system, and to translate this into effective therapies and treatments for the individual patient.